SAVIENT PHARMACEUTICALS INC
DelistedCIK 722104fmd_02X9XNRA5SRW1E9AHRJMHP15J8Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2013, 19 periods
Latest annual · FY2012
Millions- Total revenues
- 18
- Gross profit
- (4)
- Operating income
- (119)
- Net income
- (118)
- Free cash flow
- (116)
Latest quarter · Q3 FY2013
Millions- Total revenues
- 7
- Gross profit
- 5
- Operating income
- (13)
- Net income
- (20)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2009 to FY2012
- +82.6%
SAVIENT PHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $18 million | $9.6 million | +88.4% | 10-K 2013-04-01 · proof |
| Gross profit | -$4.4 million | $252,000 | -1,829.8% | 10-K 2013-04-01 · proof |
| Operating income | -$119.1 million | -$115.4 million | 10-K 2013-04-01 · proof | |
| Net income | -$118.3 million | -$102 million | 10-K 2013-04-01 · proof | |
| Cash from operating activities | -$114.7 million | -$116.9 million | 10-K 2013-04-01 · proof | |
| Free cash flow | -$116.4 million | -$117.3 million | 10-K 2013-04-01 · proof | |
| Total assets | $119.2 million | $197.1 million | -39.5% | 10-K 2013-04-01 · proof |
| Total liabilities | $257.5 million | $205.5 million | +25.3% | 10-K 2013-04-01 · proof |
| Cash and cash equivalents | $50.3 million | $114.1 million | -55.9% | 10-K 2013-04-01 · proof |
- What was SAVIENT PHARMACEUTICALS INC's revenue in fiscal 2012?
- SAVIENT PHARMACEUTICALS INC reported revenue of $18 million for fiscal 2012 (the year ended Dec 31, 2012), against $9.6 million the year before (+88.4%). Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
- What was SAVIENT PHARMACEUTICALS INC's gross profit in fiscal 2012?
- SAVIENT PHARMACEUTICALS INC reported gross profit of -$4.4 million for fiscal 2012 (the year ended Dec 31, 2012), against $252,000 the year before (-1,829.8%). Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
- What was SAVIENT PHARMACEUTICALS INC's operating income in fiscal 2012?
- SAVIENT PHARMACEUTICALS INC reported operating income of -$119.1 million for fiscal 2012 (the year ended Dec 31, 2012), against -$115.4 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
- What was SAVIENT PHARMACEUTICALS INC's net income in fiscal 2012?
- SAVIENT PHARMACEUTICALS INC reported net income of -$118.3 million for fiscal 2012 (the year ended Dec 31, 2012), against -$102 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
- What was SAVIENT PHARMACEUTICALS INC's cash from operating activities in fiscal 2012?
- SAVIENT PHARMACEUTICALS INC reported cash from operating activities of -$114.7 million for fiscal 2012 (the year ended Dec 31, 2012), against -$116.9 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
- What was SAVIENT PHARMACEUTICALS INC's free cash flow in fiscal 2012?
- SAVIENT PHARMACEUTICALS INC reported free cash flow of -$116.4 million for fiscal 2012 (the year ended Dec 31, 2012), against -$117.3 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
- What are SAVIENT PHARMACEUTICALS INC's total assets?
- As of Dec 31, 2012, SAVIENT PHARMACEUTICALS INC reported total assets of $119.2 million, against $197.1 million a year earlier (-39.5%). Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
- What are SAVIENT PHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2012, SAVIENT PHARMACEUTICALS INC reported total liabilities of $257.5 million, against $205.5 million a year earlier (+25.3%). Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
- What are SAVIENT PHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2012, SAVIENT PHARMACEUTICALS INC reported cash and cash equivalents of $50.3 million, against $114.1 million a year earlier (-55.9%). Source: the 10-K filed with the SEC on Apr 1, 2013. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:722104&period_type=annual&limit=5"Information only, not investment advice.